This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Mithra Pharmaceuticals Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Christophe Marechal
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 7.6yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 4.4yrs |
| Durata media del Consiglio di amministrazione | 2.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29AMMINISTRATORE DELEGATO
Christophe Marechal
7.6yrs
Mandato
Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-CEO & CFO | 7.6yrs | Nessun dato | Nessun dato | |
| COO & Co-CEO | less than a year | Nessun dato | Nessun dato | |
| Chief Scientific Officer | 5.2yrs | Nessun dato | Nessun dato | |
| Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Secretary of the Board & General Counsel | no data | Nessun dato | Nessun dato | |
| Compliance Officer | no data | Nessun dato | Nessun dato | |
| Communication Director | no data | Nessun dato | Nessun dato | |
| HR Director | no data | Nessun dato | Nessun dato | |
| Chief Business Officer | 3.7yrs | Nessun dato | 0.000040% € 4.9 | |
| President of the Scientific Advisory Board & Executive Director | no data | €7.12k | 0.029% € 3.6k | |
| Head of Global Regulatory Affairs | no data | Nessun dato | Nessun dato | |
| Head of Program & Project Management | no data | Nessun dato | Nessun dato |
4.4yrs
Durata media
Gestione esperta: Il team dirigenziale di MITRA è considerato esperto (durata media dell'incarico 4.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President of the Scientific Advisory Board & Executive Director | 8yrs | €7.12k | 0.029% € 3.6k | |
| Independent & Non-Executive Director | 1.7yrs | €25.00k | Nessun dato | |
| Non-Executive Director | 2.8yrs | €20.00k | 0.042% € 5.1k |
2.8yrs
Durata media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di MITRA non è considerato esperto (durata media del mandato 2.7 anni), il che suggerisce un nuovo consiglio.